Production (Stage)
Enanta Pharmaceuticals, Inc.
ENTA
$7.50
$0.091.22%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -35.61% | -35.73% | -32.91% | -40.48% | 42.95% |
Total Receivables | 2.11% | 0.64% | -2.46% | -9.32% | -14.56% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -18.98% | -19.34% | -6.41% | -10.61% | -24.52% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -30.81% | -31.30% | -29.08% | -36.10% | 29.47% |
|
|||||
Total Current Assets | -30.81% | -31.30% | -29.08% | -36.10% | 29.47% |
Net Property, Plant & Equipment | 31.35% | 130.23% | 111.29% | 84.15% | 63.95% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -16.77% | -27.02% | -27.60% | -27.78% | -10.91% |
Total Assets | -21.90% | -18.64% | -18.52% | -19.46% | 26.69% |
|
|||||
Total Accounts Payable | -29.29% | -49.32% | 95.31% | 34.58% | -42.81% |
Total Accrued Expenses | -21.79% | -8.86% | -26.13% | -29.49% | -31.34% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -11.74% | -18.63% | -10.82% | -17.44% | 656.69% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -15.86% | -21.40% | -8.36% | -14.60% | 69.77% |
|
|||||
Total Current Liabilities | -15.86% | -21.40% | -8.36% | -14.60% | 69.77% |
Long-Term Debt | -15.06% | -14.34% | -15.37% | -13.88% | 10,384.82% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 30.23% | 175.06% | 153.99% | 115.54% | 88.15% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 8.48% | -63.79% | -65.16% | -46.71% | -45.10% |
Total Liabilities | -7.27% | 0.09% | 0.94% | -2.89% | 333.58% |
|
|||||
Common Stock & APIC | 5.34% | 5.63% | 6.27% | 6.12% | 6.65% |
Retained Earnings | -35.50% | -43.65% | -56.06% | -64.47% | -94.22% |
Treasury Stock & Other | 66.42% | 94.57% | 125.72% | 56.58% | 63.25% |
Total Common Equity | -43.69% | -41.73% | -40.57% | -37.38% | -38.33% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -43.69% | -41.73% | -40.57% | -37.38% | -38.33% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -43.69% | -41.73% | -40.57% | -37.38% | -38.33% |
|